Expanded access programs are pathways for patients with serious or life-threatening diseases to access drugs in development outside of clinical trials when there are no other treatment options available. These programs are also known by other names, such as Compassionate Use, Early Access Programs, Managed Access Programs and Named Patient Programs. They are primarily driven by physicians on behalf of their patients.
Dennis Akkaya
10 Oct 2025
12 mins read
Michel van Harten
10 Oct 2025
2 mins read
Dennis Akkaya
18 Sep 2025
10 mins read
Andrea Enguita
13 Aug 2025
15 mins read
John Massarelli
7 Aug 2025
10 mins read
Michel van Harten
17 Jul 2025
4 mins read
Andrea Enguita
23 Jun 2025
15 mins read
Dennis Akkaya
28 May 2025
7 mins read
myTomorrows Team
20 May 2025
3 mins read
myTomorrows Team
8 May 2025
9 mins read